Start with the basics
It’s official, the Omnipod® 5 Automated Insulin Delivery (AID) System has been cleared by the Food and Drug Administration (FDA) for individuals ages 6 years and older with type 1 diabetes!
At Insulet Corporation, makers of Omnipod®, we were born of innovation and a thirst for finding a better, simpler way. Our goal has been and continues to be to reduce burden and improve outcomes for people with diabetes.
Diabetes wearable devices are tools that give us flexibility at our fingertips when it comes to insulin delivery.
LADA -- latent autoimmune diabetes in adults -- was first acknowledged in
For years, the HbA1c test has been the gold standard of care for assessing a person's blood sugar levels over the previous three months.
Tubed or untethered - most (not all) of us living the subcutaneous insulin delivery life - a.k.a., wearing the Omnipod® System or another insulin pump - are privy to an idiosyncratic phenomenon that happens on occasion with a new infusion site.
I love summer. Warmer temps and longer days mean more time outdoors doing some of my favorite things and, of course, applying sunscreen liberally and multiple times a day.
Since the launch of the Omnipod DASH™ System in Spring 2019, we have received many questions from the community regarding coverage. Here are some common questions and answers from our Market Access team.
I’m Dr. Trang Ly - Pediatric Endocrinologist and Medical Director here at Insulet, the makers of the Omnipod® System. I make sure that the products we develop are safe and effective for our users. Here’s a secret – I have the BEST job in the world!
Summertime is here, and with it come more days spent at the pool, beach or enjoying other outdoor activities.
In mid-2015 at the American Association of Diabetes Educators (AADE)’s annual conference, Insulet held the first Sex, Insulin, and Rock ‘N’ Roll live forum. No joke!